keyword
https://read.qxmd.com/read/38739308/carbon-nanotubes-conjugated-with-cisplatin-activate-different-apoptosis-signaling-pathways-in-2d-and-3d-spheroid-triple-negative-breast-cancer-cell-cultures-a-comparative-study
#1
JOURNAL ARTICLE
Madalina Andreea Badea, Mihaela Balas, Daniela Ionita, Anca Dinischiotu
The type of experimental model for the in vitro testing of drug formulations efficiency represents an important tool in cancer biology, with great attention being granted to three-dimensional (3D) cultures as these offer a closer approximation of the clinical sensitivity of drugs. In this study, the effects induced by carboxyl-functionalized single-walled carbon nanotubes complexed with cisplatin (SWCNT-COOH-CDDP) and free components (SWCNT-COOH and CDDP) were compared between conventional 2D- and 3D-spheroid cultures of human breast cancer cells...
May 13, 2024: Archives of Toxicology
https://read.qxmd.com/read/38739003/tabersonine-enhances-cisplatin-sensitivity-by-modulating-aurora-kinase-a-and-suppressing-epithelial-mesenchymal-transition-in-triple-negative-breast-cancer
#2
JOURNAL ARTICLE
Xi Chen, Yuanliang Yan, Yuanhong Liu, Qiaoli Yi, Zhijie Xu
CONTEXT: Tabersonine has been investigated for its role in modulating inflammation-associated pathways in various diseases. However, its regulatory effects on triple-negative breast cancer (TNBC) have not yet been fully elucidated. OBJECTIVE: This study uncovers the anticancer properties of tabersonine in TNBC cells, elucidating its role in enhancing chemosensitivity to cisplatin (CDDP). MATERIALS AND METHODS: After tabersonine (10 μM) and/or CDDP (10 μM) treatment for 48 h in BT549 and MDA-MB-231 cells, cell proliferation was evaluated using the cell counting kit-8 and colony formation assays...
December 2024: Pharmaceutical Biology
https://read.qxmd.com/read/38737908/case-report-from-negative-to-positive-a-remarkable-journey-of-er-pr-and-her2-status-in-a-patient-with-metastatic-breast-cancer
#3
Jiaqi Huang, Lan Liu, Jianghua Ding
Breast cancer is the most common malignant tumor in women, posing a serious threat to women's health. HER2 has been identified as a key oncogene and prognostic factor in breast cancer. Recent studies have reported inconsistencies in ER, PR, and/or HER2 expression between primary breast tumors and metastatic lesions. Rarely is it reported that all three biomarkers experience conversion. In this report, we present the case of a female patient with relapsed and metastatic breast cancer, whose histology transformed from initially triple-negative to Luminal-B type (HER2 positive) (i...
2024: Frontiers in Oncology
https://read.qxmd.com/read/38737746/regulation-of-cellular-and-molecular-markers-of-epithelial-mesenchymal-transition-by-brazilin-in-breast-cancer-cells
#4
JOURNAL ARTICLE
Lorena Cayetano-Salazar, Jose A Hernandez-Moreno, Jorge Bello-Martinez, Monserrat Olea-Flores, Eduardo Castañeda-Saucedo, Monica Ramirez, Miguel A Mendoza-Catalán, Napoleon Navarro-Tito
Breast cancer is the most common invasive neoplasm and the leading cause of cancer death in women worldwide. The main cause of mortality in cancer patients is invasion and metastasis, where the epithelial-mesenchymal transition (EMT) is a crucial player in these processes. Pharmacological therapy has plants as its primary source, including isoflavonoids. Brazilin is an isoflavonoid isolated from Haematoxilum brasiletto that has shown antiproliferative activity in several cancer cell lines. In this study, we evaluated the effect of Brazilin on canonical markers of EMT such as E-cadherin, vimentin, Twist, and matrix metalloproteases (MMPs)...
2024: PeerJ
https://read.qxmd.com/read/38737702/identification-of-immune-related-prognostic-biomarkers-in-triple-negative-breast-cancer
#5
JOURNAL ARTICLE
Xiao-Qing Song, Zhi-Ming Shao
BACKGROUND: Triple-negative breast cancer (TNBC), a type of breast cancer, lacks immune-related markers that can be used for prognosis or prediction. Therefore, we created a predictive framework for TNBC using a risk assessment. METHODS: Our previous study group consisted of 360 individuals who were diagnosed with TNBC through pathology using RNA sequencing and had clinical data from Fudan University Shanghai Cancer Center (FUSCC). A risk scoring model was constructed using the Cox regression method with the least absolute shrinkage and selection operator (LASSO)...
April 30, 2024: Translational Cancer Research
https://read.qxmd.com/read/38736929/comparison-of-antimicrobial-effects-of-445-and-970-nm-diode-laser-irradiation-with-photodynamic-therapy-and-triple-antibiotic-paste-on-enterococcus-faecalis-in-the-root-canal-an-in-vitro-study
#6
EDITORIAL
Narjes Hoshyari, Abbas Mesgarani, Mohammad Mahdi Sheikhi, Hamidreza Goli, Abolfazl Hossein Nataj, Nasim Chiniforush
Background and aim: Colonization of residual organisms in the root canal are major causes of root canal treatment failure. Therefore, the effective removal of organisms during root canal cleaning stages is of great importance. In this study, we aimed to investigate and compare the antimicrobial effects of several methods including high power laser irradiation, photodynamic therapy and triple antibiotic paste (TAP) on Enterococcus faecalis in the root canal. Materials and methods: For the present laboratory study, 80 anterior single canal teeth were randomly divided into seven experimental groups (970 nm diode laser irradiation, 445 nm diode laser irradiation, 660 nm photodynamic therapy with doxycycline as a photosensitizer, TAP, 970 nm diode laser combined with TAP, 445 nm diode laser combined with TAP and sodium hypochlorite groups), each containing 10 teeth, and two positive and negative control groups, each containing five teeth...
March 2024: Mædica
https://read.qxmd.com/read/38736017/retraction-note-ensemble-learning-based-gene-signature-and-risk-model-for-predicting-prognosis-of-triple-negative-breast-cancer
#7
Tiancheng Li, Siqi Chen, Yuqi Zhang, Qianqian Zhao, Kai Ma, Xiwei Jiang, Rongwu Xiang, Fei Zhai, Guixia Ling
No abstract text is available yet for this article.
May 13, 2024: Functional & Integrative Genomics
https://read.qxmd.com/read/38735931/ternary-heterostructure-driven-photoinduced-electron-hole-separation-enhanced-oxidative-stress-for-triple-negative-breast-cancer-therapy
#8
JOURNAL ARTICLE
Shuqing Dong, Yuqi Huang, Hanrong Yan, Huarong Tan, Liying Fan, Minghao Chao, Yiping Ren, Ming Guan, Jiaxin Zhang, Zhao Liu, Fenglei Gao
Zinc oxide nanoparticles (ZnO NPs) stand as among the most significant metal oxide nanoparticles in trigger the formation of reactive oxygen species (ROS) and induce apoptosis. Nevertheless, the utilization of ZnO NPs has been limited by the shallowness of short-wavelength light and the constrained production of ROS. To overcome these limitations, a strategy involves achieving a red shift towards the near-infrared (NIR) light spectrum, promoting the separation and restraining the recombination of electron-hole (e- -h+ ) pairs...
May 12, 2024: Journal of Nanobiotechnology
https://read.qxmd.com/read/38735837/a-comprehensive-overview-of-metaplastic-breast-cancer-features-and-treatments
#9
REVIEW
Qiaoke Yan, Yuwei Deng, Qingyuan Zhang
Metaplastic breast cancer is a rare, aggressive, and chemotherapy-resistant subtype of breast cancers, accounting for less than 1% of invasive breast cancers, characterized by adenocarcinoma with spindle cells, squamous epithelium, and/or mesenchymal tissue differentiation. The majority of metaplastic breast cancers exhibit the characteristics of triple-negative breast cancer and have unfavorable prognoses with a lower survival rate. This subtype often displays gene alterations in the PI3K/AKT pathway, Wnt/β-catenin pathway, and cell cycle dysregulation and demonstrates epithelial-mesenchymal transition, immune response changes, TP53 mutation, EGFR amplification, and so on...
May 12, 2024: Cancer Science
https://read.qxmd.com/read/38735772/an-mrt-workforce-shortage-is-no-laughing-matter
#10
JOURNAL ARTICLE
Laura Zychla, Mark R Given
The Canadian Association of Medical Radiation Technologists (CAMRT) has collected profession-specific health human resource (HHR) and impact data to understand medical radiation technologist (MRT) workforce models. The cumulation of these efforts provides longstanding HHR trends that can inform medical imaging and radiation therapy departments. The data demonstrates the healthcare system is neglecting workplace safety across Canada and is causing negative physical and psychological impacts on MRTs as a direct result...
May 11, 2024: Journal of Medical Imaging and Radiation Sciences
https://read.qxmd.com/read/38734935/function-and-mechanism-of-action-of-the-trpv1-channel-in-the-development-of-triple-negative-breast-cancer
#11
JOURNAL ARTICLE
Ziling Yan, Haihui Huang, Qianqian Wang, Yanjie Kong, Xia Liu
Transient receptor potential channel subfamily vanilloid 1 (TRPV1) is a member of the transient receptor potential family of nonselective cationic transmembrane channel proteins that are involved in the regulation of calcium homeostasis. It is expressed in various tumor types and has been implicated in the regulation of cancer growth, metastasis, apoptosis, and cancer-related pain. TRPV1 is highly expressed in triple-negative breast cancer (TNBC), and both its agonists and antagonists may exert anti-cancer effects...
May 11, 2024: Acta Biochimica et Biophysica Sinica
https://read.qxmd.com/read/38734640/erianin-inhibits-the-progression-of-triple-negative-breast-cancer-by-suppressing-src-mediated-cholesterol-metabolism
#12
JOURNAL ARTICLE
Ming Li, Shiyao Kang, Xuming Deng, Huimin Li, Yuan Zhao, Wenru Tang, Miaomiao Sheng
Triple-negative breast cancer (TNBC) is highly malignant and lacks effective biotherapeutic targets. The development of efficient anticancer drugs with low toxicity and few side effects is a hotspot in TNBC treatment research. Although erianin is known to have potent antitumor activity, its regulatory mechanism and target in TNBC have not been fully elucidated, hampering further drug development. This study showed that erianin can significantly inhibit TNBC cell proliferation and migration, promote cell apoptosis, and inhibit the growth of transplanted tumors in mice...
May 11, 2024: Cancer Cell International
https://read.qxmd.com/read/38734591/metaplastic-breast-cancer-with-a-unique-presentation-and-complete-response-to-chemotherapy-a-case-report
#13
JOURNAL ARTICLE
Fouad Nahhat, Modar Doyya, Kareem Zabad, Hazem Ksiri
BACKGROUND: Metaplastic breast carcinomas are a rare variant group of breast carcinomas. They are usually high-grade and triple-negative tumors. They often present with large primary tumor sizes. However, the involvement of axillary lymph nodes is infrequent at the time of diagnosis. Metaplastic breast carcinomas are associated with a worse prognosis and a poorer response to chemotherapy in comparison with other non-metaplastic triple-negative breast cancers. Up until this point, there are no specific treatment recommendations for metaplastic breast carcinomas beyond those intended for invasive breast cancer in general...
May 11, 2024: BMC Women's Health
https://read.qxmd.com/read/38734115/glucocorticoid-receptor-mediated-oncogenic-activity-is-dependent-on-breast-cancer-subtype
#14
JOURNAL ARTICLE
B Clark Abigail, D Conzen Suzanne
Breast cancer incidence has been steadily rising and is the leading cause of cancer death in women due to its high metastatic potential. Individual breast cancer subtypes are classified by both cell type of origin and receptor expression, namely estrogen, progesterone and human epidermal growth factor receptors (ER, PR and HER2). Recently, the importance and context-dependent role of glucocorticoid receptor (GR) expression in the natural history and prognosis of breast cancer subtypes has been uncovered. In ER-positive breast cancer, GR expression is associated with a better prognosis as a result of ER-GR crosstalk...
May 9, 2024: Journal of Steroid Biochemistry and Molecular Biology
https://read.qxmd.com/read/38733700/screening-optimal-candidates-with-operable-early-stage-triple-negative-breast-cancer-benefitting-from-capecitabine-maintenance-a-post-hoc-analysis-of-the-sysucc-001-study
#15
JOURNAL ARTICLE
Fangfang Duan, Xin Hua, Xiwen Bi, Shusen Wang, Yanxia Shi, Fei Xu, Li Wang, Jiajia Huang, Zhongyu Yuan, Yuanyuan Huang
BACKGROUND: To explore whether specific clinicopathological covariates are predictive for a benefit from capecitabine maintenance in early-stage triple-negative breast cancer (TNBC) in the SYSUCC-001 phase III clinical trial. METHODS: Candidate covariates included age, menstrual status, type of surgery, postoperative chemotherapy regimen, Ki-67 percentage, histologic grade, primary tumor size, lymphovascular invasion, node status, and capecitabine medication...
May 6, 2024: Breast: Official Journal of the European Society of Mastology
https://read.qxmd.com/read/38733508/cholesteryl-ester-transfer-protein-knock-down-in-conjunction-with-a-cholesterol-depleting-agent-decreases-tamoxifen-resistance-in-breast-cancer-cells
#16
JOURNAL ARTICLE
Liang Gu, Ruvesh Pascal Pillay, Ruth Aronson, Mandeep Kaur
The cholesterogenic phenotype, encompassing de novo biosynthesis and accumulation of cholesterol, aids cancer cell proliferation and survival. Previously, the role of cholesteryl ester (CE) transfer protein (CETP) has been implicated in breast cancer aggressiveness, but the molecular basis of this observation is not clearly understood, which this study aims to elucidate. CETP knock-down resulted in a >50% decrease in cell proliferation in both 'estrogen receptor-positive' (ER+; Michigan Cancer Foundation-7 (MCF7) breast cancer cells) and 'triple-negative' breast cancer (TNBC; MDA-MB-231) cell lines...
May 11, 2024: IUBMB Life
https://read.qxmd.com/read/38732271/clinicopathological-significance-of-cyclin-dependent-kinase-2-cdk2-in-ductal-carcinoma-in-situ-and-early-stage-invasive-breast-cancers
#17
JOURNAL ARTICLE
Ayat Lashen, Shatha Alqahtani, Ahmed Shoqafi, Mashael Algethami, Jennie N Jeyapalan, Nigel P Mongan, Emad A Rakha, Srinivasan Madhusudan
Cyclin-dependent kinase 2 (CDK2) is a key cell cycle regulator, with essential roles during G1/S transition. The clinicopathological significance of CDK2 in ductal carcinomas in situ (DCIS) and early-stage invasive breast cancers (BCs) remains largely unknown. Here, we evaluated CDK2's protein expression in 479 BC samples and 216 DCIS specimens. Analysis of CDK2 transcripts was completed in the METABRIC cohort ( n = 1980) and TCGA cohort ( n = 1090), respectively. A high nuclear CDK2 protein expression was significantly associated with aggressive phenotypes, including a high tumour grade, lymph vascular invasion, a poor Nottingham prognostic index (all p -values < 0...
May 6, 2024: International Journal of Molecular Sciences
https://read.qxmd.com/read/38731867/type-ii-interleukin-4-receptor-activation-in-basal-breast-cancer-cells-promotes-tumor-progression-via-metabolic-and-epigenetic-modulation
#18
JOURNAL ARTICLE
Demond Williams, Ebony Hargrove-Wiley, Wendy Bindeman, Daniel Valent, Adam X Miranda, Jacob Beckstead, Barbara Fingleton
Interleukin-4 (IL4) is a Th2 cytokine that can signal through two different receptors, one of which-the type II receptor-is overexpressed by various cancer cells. Previously, we have shown that type II IL4 receptor signaling increases proliferation and metastasis in mouse models of breast cancer, as well as increasing glucose and glutamine metabolism. Here, we expand on those findings to determine mechanistically how IL4 signaling links glucose metabolism and histone acetylation to drive proliferation in the context of triple-negative breast cancer (TNBC)...
April 24, 2024: International Journal of Molecular Sciences
https://read.qxmd.com/read/38730959/quantum-dot-research-in-breast-cancer-challenges-and-prospects
#19
REVIEW
Hossein Omidian, Renae L Wilson, Luigi X Cubeddu
The multifaceted role of quantum dots (QDs) in breast cancer research highlights significant advancements in diagnostics, targeted therapy, and drug delivery systems. This comprehensive review addresses the development of precise imaging techniques for early cancer detection and the use of QDs in enhancing the specificity of therapeutic delivery, particularly in challenging cases like triple-negative breast cancer (TNBC). The paper also discusses the critical understanding of QDs' interactions with cancer cells, offering insights into their potential for inducing cytotoxic effects and facilitating gene therapy...
May 4, 2024: Materials
https://read.qxmd.com/read/38730707/activation-of-the-anaphase-promoting-complex-restores-impaired-mitotic-progression-and-chemosensitivity-in-multiple-drug-resistant-human-breast-cancer
#20
JOURNAL ARTICLE
Mathew Lubachowski, Cordell VanGenderen, Sarah Valentine, Zach Belak, Gerald Floyd Davies, Terra Gayle Arnason, Troy Anthony Alan Harkness
The development of multiple-drug-resistant (MDR) cancer all too often signals the need for toxic alternative therapy or palliative care. Our recent in vivo and in vitro studies using canine MDR lymphoma cancer cells demonstrate that the Anaphase Promoting Complex (APC) is impaired in MDR cells compared to normal canine control and drug-sensitive cancer cells. Here, we sought to establish whether this phenomena is a generalizable mechanism independent of species, malignancy type, or chemotherapy regime. To test the association of blunted APC activity with MDR cancer behavior, we used matched parental and MDR MCF7 human breast cancer cells, and a patient-derived xenograft (PDX) model of human triple-negative breast cancer...
April 30, 2024: Cancers
keyword
keyword
4622
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.